BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29408435)

  • 1. Serological diagnosis and prognostic of tegumentary and visceral leishmaniasis using a conserved Leishmania hypothetical protein.
    Dias DS; Ribeiro PAF; Salles BCS; Santos TTO; Ramos FF; Lage DP; Costa LE; Portela ASB; Carvalho GB; Chávez-Fumagalli MA; Caligiorne RB; Oliveira JS; Magalhães-Soares DF; Silva ES; Galdino AS; Menezes-Souza D; Duarte MC; Gonçalves DU; Coelho EAF
    Parasitol Int; 2018 Jun; 67(3):344-350. PubMed ID: 29408435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a hypothetical protein for serodiagnosis and as a potential marker for post-treatment serological evaluation of tegumentary leishmaniasis patients.
    Lima MP; Costa LE; Duarte MC; Menezes-Souza D; Salles BCS; de Oliveira Santos TT; Ramos FF; Chávez-Fumagalli MA; Kursancew ACS; Ambrósio RP; Roatt BM; Machado-de-Ávila RA; Gonçalves DU; Coelho EAF
    Parasitol Res; 2017 Apr; 116(4):1197-1206. PubMed ID: 28150041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ELISA immunoassay employing a conserved Leishmania hypothetical protein for the serodiagnosis of visceral and tegumentary leishmaniasis in dogs and humans.
    Carvalho AMRS; Costa LE; Salles BCS; Santos TTO; Ramos FF; Lima MP; Chávez-Fumagalli MA; Silvestre BT; Portela ÁSB; Roatt BM; Silveira JAG; Gonçalves DU; Magalhães-Soares DF; Duarte MC; Menezes-Souza D; Coelho EAF
    Cell Immunol; 2017 Aug; 318():42-48. PubMed ID: 28602279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human disease.
    Machado AS; Ramos FF; Santos TTO; Costa LE; Ludolf F; Lage DP; Bandeira RS; Tavares GSV; Oliveira-da-Silva JA; Steiner BT; Chaves AT; Oliveira JS; Chávez-Fumagalli MA; de Magalhães-Soares DF; Silveira JAG; Duarte MC; Machado-de-Ávila RA; Lyon S; Gonçalves DU; Caligiorne RB; Coelho EAF
    Exp Parasitol; 2020 Sep; 216():107941. PubMed ID: 32622940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasis.
    Oliveira-da-Silva JA; Machado AS; Ramos FF; Tavares GSV; Lage DP; Ludolf F; Steiner BT; Reis TAR; Santos TTO; Costa LE; Martins VT; Galvani NC; Chaves AT; Oliveira JS; Chávez-Fumagalli MA; de Magalhães-Soares DF; Duarte MC; Menezes-Souza D; Silveira JAG; Moreira RLF; Machado-de-Ávila RA; Tupinambás U; Gonçalves DU; Coelho EAF
    Immunol Lett; 2020 Apr; 220():11-20. PubMed ID: 31981576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conserved Leishmania hypothetical protein evaluated for the serodiagnosis of canine and human visceral and tegumentary leishmaniasis, as well as a serological marker for the posttreatment patient follow-up.
    Ribeiro PAF; Dias DS; Lage DP; Costa LE; Salles BCS; Steiner BT; Ramos FF; Lima MP; Santos TTO; Chaves AT; Chávez-Fumagalli MA; Fujiwara RT; Bueno LL; Caligiorne RB; de Magalhães-Soares DF; Silveira JAG; Machado-de-Ávila RA; Gonçalves DU; Coelho EAF
    Diagn Microbiol Infect Dis; 2018 Nov; 92(3):196-203. PubMed ID: 29941364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of two recombinant Leishmania proteins identified by an immunoproteomic approach as tools for the serodiagnosis of canine visceral and human tegumentary leishmaniasis.
    Coelho EA; Costa LE; Lage DP; Martins VT; Garde E; de Jesus Pereira NC; Lopes EG; Borges LF; Duarte MC; Menezes-Souza D; de Magalhães-Soares DF; Chávez-Fumagalli MA; Soto M; Tavares CA
    Vet Parasitol; 2016 Jan; 215():63-71. PubMed ID: 26790739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Leishmania eukaryotic elongation factor-1 beta protein: A potential diagnostic antigen to detect tegumentary and visceral leishmaniasis in dogs and humans.
    Santos TTO; Cardoso MS; Machado AS; Siqueira WF; Ramos FF; Oliveira-da-Silva JA; Tavares GSV; Lage DP; Costa LE; de Freitas CS; Martins VT; Bandeira RS; Chávez-Fumagalli MA; Lyon S; Moreira RLF; de Magalhães-Soares DF; Silveira JAG; Tupinambás U; Caligiorne RB; Chaves AT; Rocha MOC; Fujiwara RT; Coelho EAF
    Microb Pathog; 2019 Dec; 137():103783. PubMed ID: 31600536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope mapping of the HSP83.1 protein of Leishmania braziliensis discloses novel targets for immunodiagnosis of tegumentary and visceral clinical forms of leishmaniasis.
    Menezes-Souza D; Mendes TA; Gomes Mde S; Reis-Cunha JL; Nagem RA; Carneiro CM; Coelho EA; Galvão LM; Fujiwara RT; Bartholomeu DC
    Clin Vaccine Immunol; 2014 Jul; 21(7):949-59. PubMed ID: 24807053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of ELISA employing Leishmania (Viannia) braziliensis and Leishmania (Leishmania) chagasi antigens for the detection of IgG and IgG1 and IgG2 subclasses in the diagnosis of American tegumentary leishmaniasis in dogs.
    Ribeiro FC; de O Schubach A; Mouta-Confort E; Schubach TM; de Fátima Madeira M; Marzochi MC
    Vet Parasitol; 2007 Sep; 148(3-4):200-6. PubMed ID: 17689193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proteomic road to acquire an accurate serological diagnosis for human tegumentary leishmaniasis.
    Lima BS; Pires SF; Fialho LC; Oliveira EJ; Machado-de-Avila RA; Chávez-Olórtegui C; Chapeaurouge AD; Perales J; Andrade HM
    J Proteomics; 2017 Jan; 151():174-181. PubMed ID: 27262223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential application of small myristoylated protein-3 evaluated as recombinant antigen and a synthetic peptide containing its linear B-cell epitope for the serodiagnosis of canine visceral and human tegumentary leishmaniasis.
    Salles BCS; Dias DS; Steiner BT; Lage DP; Ramos FF; Ribeiro PAF; Santos TTO; Lima MP; Costa LE; Chaves AT; Chávez-Fumagalli MA; Fujiwaraa RT; Buenoa LL; Caligiorne RB; de Magalhães-Soares DF; Silveira JAG; Machado-de-Ávila RA; Gonçalves DU; Coelho EAF
    Immunobiology; 2019 Jan; 224(1):163-171. PubMed ID: 30266201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The true significance of serological exams in the diagnosis of endemic diseases].
    Teixeira AR; Vexenat Ade C
    Rev Soc Bras Med Trop; 1996; 29(4):379-82. PubMed ID: 8768590
    [No Abstract]   [Full Text] [Related]  

  • 14. A Leishmania infantum hypothetical protein evaluated as a recombinant protein and specific B-cell epitope for the serodiagnosis and prognosis of visceral leishmaniasis.
    Machado AS; Ramos FF; Oliveira-da-Silva JA; Santos TTO; Ludolf F; Tavares GSV; Costa LE; Lage DP; Steiner BT; Chaves AT; Chávez-Fumagalli MA; de Magalhães-Soares DF; Silveira JAG; Napoles KMN; Tupinambás U; Duarte MC; Machado-de-Ávila RA; Bueno LL; Fujiwara RT; Moreira RLF; Rocha MOC; Caligiorne RB; Coelho EAF
    Acta Trop; 2020 Mar; 203():105318. PubMed ID: 31870709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Cysteine Proteinase B from Leishmania braziliensis and Its Domains: Promising Antigens for Serodiagnosis of Cutaneous and Visceral Leishmaniasis in Dogs.
    Bivona AE; Czentner L; Sanchez Alberti A; Cerny N; Cardoso Landaburu AC; Nevot C; Estévez O; Marco JD; Basombrio MA; Malchiodi EL; Cazorla SI
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31434727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis.
    Boarino A; Scalone A; Gradoni L; Ferroglio E; Vitale F; Zanatta R; Giuffrida MG; Rosati S
    Clin Diagn Lab Immunol; 2005 May; 12(5):647-53. PubMed ID: 15879027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteins Selected in Leishmania (Viannia) braziliensis by an Immunoproteomic Approach with Potential Serodiagnosis Applications for Tegumentary Leishmaniasis.
    Duarte MC; Pimenta DC; Menezes-Souza D; Magalhães RD; Diniz JL; Costa LE; Chávez-Fumagalli MA; Lage PS; Bartholomeu DC; Alves MJ; Fernandes AP; Soto M; Tavares CA; Gonçalves DU; Rocha MO; Coelho EA
    Clin Vaccine Immunol; 2015 Nov; 22(11):1187-96. PubMed ID: 26376929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenicity of phage clones and their synthetic peptides for the serodiagnosis of canine and human visceral leishmaniasis.
    Costa LE; Salles BCS; Santos TTO; Ramos FF; Lima MP; Lima MIS; Portela ÁSB; Chávez-Fumagalli MA; Duarte MC; Menezes-Souza D; Machado-de-Ávila RA; Silveira JAG; Magalhães-Soares DF; Goulart LR; Coelho EAF
    Microb Pathog; 2017 Sep; 110():14-22. PubMed ID: 28629727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A biomarker for tegumentary and visceral leishmaniasis based on a recombinant Leishmania hypothetical protein.
    Lage DP; Machado AS; Ramos FF; Silveira PC; Dias DS; Ribeiro PAF; Tavares GSV; Costa LE; Santos TTO; Steiner BT; Fagundes MI; Chávez-Fumagalli MA; Lyon S; Moreira RLF; Duarte MC; Menezes-Souza D; Caligiorne RB; Machado-de-Ávila RA; Teixeira AL; Coelho EAF
    Immunobiology; 2019 Jul; 224(4):477-484. PubMed ID: 31164242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific K39 antibody response and its persistence after treatment in patients with imported leishmaniasis.
    Reiter-Owona I; Rehkaemper-Schaefer C; Arriens S; Rosenstock P; Pfarr K; Hoerauf A
    Parasitol Res; 2016 Feb; 115(2):761-9. PubMed ID: 26508007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.